Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

Global Spinal Implants Market

Spine disorders are a leading driver of healthcare costs worldwide, and range in severity from mild pain and loss of feeling to extreme pain and paralysis. These disorders are primarily caused by degenerative conditions in the spine, deformity, tumors and trauma.

December 1, 2015

Find out more

U.S. Patient Monitoring Devices Market, November 2015

$5,250.00

This report provides a summary of the nearly $2 billion U.S. patient monitoring devices market.

November 2, 2015

Find out more

U.S. Markets for Drug and Fluid Delivery Devices

$5,250.00

Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S.

December 1, 2015

Find out more

Asia-Pacific: Surgical Procedure Volumes

$5,250.00

This report examines the healthcare trends in Asia-Pacific countries (Japan, China, South Korea, India, Thailand, Vietnam, Malaysia and Australia), as well as analyzes and forecasts (toward 2019).

September 1, 2015

Find out more

U.S. Neurostimulation Devices Market, June 2015

$5,250.00

An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.

September 22, 2016

Find out more

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

September 22, 2016

Find out more

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

$5,250.00

The United States (U.S.) market for orthopedic extremity and soft tissue repair products encompasses interventional surgical procedures and biologic and synthetic implants used in the repair of bone, joints, and soft tissue that have been damaged as a result of disease or due to physical injury.

September 1, 2015

Find out more

PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

$7,500.00

Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) has outpaced Merck’s Keytruda (pembrolizumab) primarily
in non-small cell lung cancer (NSCLC) because of its early approval in squamous NSCLC, updated National
Comprehensive Cancer Network (NCCN) guidelines in 2015,

December 22, 2016

Find out more

The Global Molecular Diagnostics Market

$6,250.00

The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

September 22, 2016

Find out more

MedTech analysis

Global Spinal Implants Market

U.S. Patient Monitoring Devices Market, November 2015

U.S. Markets for Drug and Fluid Delivery Devices

Asia-Pacific: Surgical Procedure Volumes

U.S. Neurostimulation Devices Market, June 2015

U.S. Markets for Obesity Drugs & Devices

U.S. Markets for Orthopedic Extremity and Soft Tissue Repair, September 2015

PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

The Global Molecular Diagnostics Market